ClinicalTrials.gg
CompletedNCT02363985Updated Dec 12, 2017

Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection

An interventional study of Mega-dose of vitamin A supplement in Vitamin A Deficiency, sponsored by Ethiopian Public Health Institute. Completed at 1 site in Ethiopia. Open to participants aged 3 Years to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-12-12.

Sponsored by Ethiopian Public Health Institute · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

The combination of infectious diseases and malnutrition is the most prevalent, preventable public health problem in the world, responsible for millions of deaths annually, particularly in infants and children. Approximately 13 million children die each year in developing countries from infectious diseases, with the majority of these deaths related to malnutrition. The relationship between infections and malnutrition is synergistic, each further compromising the outcome of the other. Malnutrition compromises natural immunity leading to increased susceptibility to infections, more frequent and prolonged disease episodes, and increased severity of disease. Likewise, infections can aggravate or precipitate malnutrition through decreased appetite and food intake, nutrient malabsorption, nutrient loss or increased metabolic needs. Another issue is that infections (as well as overweight and obesity status) affect nutritional biomarkers making it difficult to assess the real magnitude of some nutritional problems. This is the case of vitamin A. Vitamin A deficiency is defined to be of severe public health importance if 20% or more of a defined population has a serum retinol concentration of less than 0.7 µmol/L. However, circulating concentrations of serum retinol are reduced by infections and in such situations serum retinol concentration is not a good indicator of vitamin A status. Serum acute-phase proteins can indicate the severity and duration of an infection. Correcting vitamin A deficiency is addressed in Ethiopia through vitamin A supplementation of children, dietary diversity and using bio-fortified foods. However, assessing vitamin A status, and the effectiveness of government interventions, is challenging in settings where infectious diseases are endemic, as in most area of the country. Evaluation of vitamin A status is relatively insensitive when based on changes in serum retinol concentrations, which are homeostatically controlled and negatively affected by subclinical infections. Liver stores of vitamin A, the best indicator of vitamin A status, cannot be routinely evaluated. The isotope dilution technique is the preferred method for determining vitamin A status and assessing the efficacy and effectiveness of intervention programs aimed at improving vitamin A status. It is the only indirect assessment method that provides a quantitative estimate of vitamin A status across the continuum of deficient to excessive stores.

Read the detailed description

Vitamin A deficiency is the leading cause of preventable blindness in children and is associated with a higher risk of under five mortality. Approximately 250,000 to 500,000 children in developing countries become blind each year owing to vitamin A deficiency, with the highest prevalence in South Asia and Africa. In Africa, many countries have implemented vitamin A interventions of mega-dose supplementation for children under 5 years, sometimes in combination with food fortification programs.

Vitamin A deficiency is a major nutritional concern; with more than 37.7% of under five children being vitamin A deficient by serum retinol and 50.7% had been sick in the previous 15 days in Ethiopia. Vitamin A deficiency is addressed in the country through vitamin A supplementation every six months for 6-59 months of children and during the first 45 days of delivery for lactating mothers. There are also other vitamin A intervention programs like bio-fortification of orange flesh sweet potato (OFSP) in pocket areas. Unfortunately, assessing vitamin A status, and the effectiveness of government interventions, is challenging in settings where infectious diseases are endemic, as in most African countries including Ethiopia. This is because serum retinol concentration decreases during infection due to the acute phase response.

The overall national prevalence of any helminthes infection in Ethiopia was 29.8% with variable degree of prevalence among regions, where by southern nation nationality people (SNNP) (51%) and Gambella (51%) have the highest prevalence. A survey in 13 foods for education program-supported schools in the SNNP region indicated that prevalence of soil transmitted helminthiasis infections are 44.4%. The proportion of school children infected with any parasite species was 55.4%. A. lumbricoides was the most prevalent species 32.1%, followed by hookworm 21.7%.

Forty seven subjects (26 male and 21 female) met the survey definition of smear positive tuberculosis (TB) cases, with a prevalence of 108/100,000 (72-138). From smear positive TB cases, 37(78.7%) were new cases, 2(4.3%) were on treatment, and 8(17%) were previously treated in the last five years. Malaria prevalence is 4.5% in the malaria endemic area.

Evaluation of Vitamin A status is relatively insensitive when based on changes in serum retinol, which is homeostatically controlled and negatively affected by subclinical infections. Liver stores of vitamin A are the best indicator of vitamin A status, but cannot be routinely evaluated. The isotope dilution technique is the preferred method for determining vitamin A status and assessing the efficiency and effectiveness of intervention programs. It is the only indirect assessment method that provides a quantitative estimate of vitamin A status across the continuum from deficient to excessive vitamin A.

Hence, this project will assess the vitamin A and inflammatory status of 3-5 year old children 4-5 months after their semi-annual mega-dose vitamin A supplementation. The results will indicate the proportions of sampled children with low, normal or high vitamin A status, how inflammation (from obesity or recent infection or injury) affects assessment of vitamin A status using different vitamin A assessment methods, and how status differs by country, in possible association with food fortification practices.

Gap /Problem /Needs Analysis

The combination of infectious diseases and malnutrition is the most prevalent, preventable public health problem in the world, responsible for millions of deaths annually, particularly in infants and children. Approximately 13 million children die each year in developing countries from infectious diseases, with the majority of these deaths related to malnutrition. The relationship between infections and malnutrition is synergistic, each further compromising the outcome of the other. Malnutrition compromises natural immunity leading to increased susceptibility to infections, more frequent and prolonged disease episodes, and increased severity of disease. Likewise, infections can aggravate or precipitate malnutrition through decreased appetite and food intake, nutrient mal-absorption, nutrient loss or increased metabolic needs. Severe malnutrition often masks symptoms and signs of infectious diseases making prompt clinical diagnosis and treatment very difficult. Another issue is that infections (as well as overweight and obesity status) affect nutritional biomarkers making it difficult to assess the real magnitude of some nutritional problems. This is the case of vitamin A. Vitamin A deficiency is defined to be of severe public health importance if 20% or more of a defined population has a serum retinol concentration of less than 0.7 µmol/L. However, circulating concentrations of serum retinol are reduced by infections and in such situations serum retinol concentration is not a good indicator of vitamin A status. Infections are accompanied by an acute phase response, and serum acute-phase proteins can indicate the severity and duration of an infection. Acute-phase proteins, such as C-reactive protein (CRP), increase within the first 6h of infection, and reach their maximum concentrations within 24-48h. However, α1-acid-glycoprotein (AGP) rises more slowly, with maximum concentrations 2-5 days after infection. Vitamin A deficiency is a major nutritional concern in poor societies affecting 190 million children globally.

Vitamin A is an essential nutrient needed for the visual system, and maintenance of cell function for growth, epithelial integrity, red blood cell production, immunity and reproduction. All infants are born with low stores and depend on vitamin A from breast milk to initially accumulate and maintain adequate stores. Infants of vitamin A depleted women are at greater risk of becoming vitamin A deficient early in life, especially if they are not breast fed. Correcting vitamin A deficiency is addressed by some African countries through vitamin A supplementation of children and food fortification programs. However, assessing vitamin A status, and the effectiveness of government interventions, is challenging in settings where infectious diseases are endemic, as in most African countries. Evaluation of vitamin A status is relatively insensitive when based on changes in serum retinol concentrations, which are homeostatically controlled and negatively affected by subclinical infections. Liver stores of vitamin A, the best indicator of vitamin A status, cannot be routinely evaluated. The isotope dilution technique is the preferred method for determining vitamin A status and assessing the efficacy and effectiveness of intervention programs aimed at improving vitamin A status. It is the only indirect assessment method that provides a quantitative estimate of vitamin A status across the continuum of deficient to excessive stores. Thus, this technique can be used for assessing vitamin A status in populations at risk of excessive status due to exposure to too much vitamin A through combined supplementation and consumption of fortified foods and/or preformed vitamin A-rich foods. The aim of this project is to use nuclear techniques to evaluate vitamin A nutritional status of young children during semi-annual administration of vitamin A supplements, and to assess how this relates to infection status.

The International Atomic Energy Agency (IAEA) has provided significant support on use of stable isotopes in assessing body composition and breast milk to Member States in Africa, it is now establishing the stable isotope technique to assess vitamin A body stores in Cameroon and Zambia (and additional implementation is possible in other country) for use throughout the region. These inputs will be used in this project to provide key information to stakeholders on how vitamin A intervention programs affect vitamin A status in children and how infections affect vitamin A status or validity of stable isotope techniques.

Role of nuclear technology The nuclear techniques used will be the deuterated- and 13 Carbon-retinol body pool measurements to assess vitamin A status. These nuclear methods are useful across the continuum of nutritional status from deficient to adequate to excess, in contrast with the more common measurement of serum retinol concentrations. In addition, the presence of infection/inflammation is less likely to interfere with interpretation of the nuclear method than that of the serum retinol method, but this will be investigated in this series of studies. This method is already being established in 2-3 countries and the serum retinol method is established in approximately 8 countries. Further use of the deuterated retinol body pool size nuclear method will contribute to capacity building in Africa, where vitamin A supplementation of children and widespread fortification are routine. The combination of multiple vitamin A interventions requires continuous monitoring. The IAEA is expected to provide technical and logistical support for the use of isotope dilution methods and facilitate Fellowships, Training, Scientific Visits, Expert Missions and Supplies.

02

Conditions studied

  • Vitamin A Deficiency

Browse trials for

03

In context

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

This study's enrollment of 138 is below the median of 200 across 49 interventional studies indexed under Vitamin A Deficiency.

Browse Vitamin A Deficiency studies →

Lead sponsor

Ethiopian Public Health Institute is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 3-5 years, planning to move from the study area for the duration of the study, and do not have severe illness at the time of enrollment.

Exclusion criteria

Exclusion Criteria:

  • severe anaemia, severe acute malnutrition, obesity or clinically defined severe illness, such as dehydration, severe diarrhoea or severe respiratory illness.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (actual)

Study arms

  • Other
    Multiple vitamin A exposer

    55 children who are using * Mega-dose vitamin A supplementation * Food diversification (promotion and education on vitamin A rich food consumption) * Promotion of orange flash sweet potato production and consumption in collaboration with international potato center (CIP) in one of the study area

    Dietary Supplement: Mega-dose of vitamin A supplement

  • Other
    Only vitamin A supplementation

    55 children who are using * Mega-dose vitamin A supplementation * Food diversification (promotion and education on vitamin A rich food consumption)

    Dietary Supplement: Mega-dose of vitamin A supplement

Interventions

  • Dietary supplementMega-dose of vitamin A supplement

    vitamin A supplementation normally given every six months for under five children in Ethiopia. In addition, there is also dietary intervention like orange flash sweet potato and promotion of other vitamin A rich foods to tackle vitamin A deficiency in Ethiopia.

06

What researchers measure

Primary outcomes

  1. Total body pool size vitamin A (µmol)

    estimate the total body pool size vitamin A in preschool child in Ethiopia using stable isotope technique

    Time frame: within the coming 2 years

  2. Liver Vitamin A store (µmol/g)

    Liver Vit A store (µmol/g) cut off \<= 0.07

    Time frame: within the coming 2 years

  3. Serum retinol (µmol/l)

    Serum retinol (µmol/l) cut off \<= 0.7

    Time frame: within the coming 2 years

Secondary outcomes

  1. level of infection

    AGP and CRP

    Time frame: within the coming 2 years

  2. dietary intake

    mean intake of beta carotene and dietary diversity score using 24 hour dietary recall

    Time frame: within the coming 2 years

  3. Anthropometry measurement

    Weight for Height Z-score, Weight for Age Z-score, Height for Age Z-score and middle upper arm circumference

    Time frame: within the coming 2 years

  4. socioeconomic status

    household (HH) family size, marital status of the mother, head of the HH, source of drinking wate, highest level of education the head of HH attend

    Time frame: within the coming 2 years

  5. Morbidity

    medical history of the child enrolled in the study such as diarrhea, cough, fever, malaria, rashes, measles, vaccination, vitamin A supplementation, durg for intestinal deworming, iron supplementation.

    Time frame: within the coming 2 years

07

Study locations

1 site
  • Ethiopian Public Health Institute
    Addis Ababa, 1242, Ethiopia
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2017 to primary completion in Jun 2017, 3 months.

Of 19 interventional studies with no phase under Vitamin A Deficiency, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2015
First posted
Feb 16, 2015
StartActual
Mar 1, 2017
Primary completionActual
Jun 30, 2017
CompletionActual
Jun 30, 2017
Last update
Dec 12, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02363985
Lead sponsor
Ethiopian Public Health Institute
Collaborators
International Atomic Energy Agency
Responsible party
Tesfaye Hailu (Researcher, Ethiopian Public Health Institute) — Principal investigator
First posted
Feb 16, 2015
Start date
Mar 1, 2017
Primary completion
Jun 30, 2017
Completion
Jun 30, 2017
Last update
Dec 12, 2017

Study contacts

Cornelia Loechl, PhD
study director · International Atomic Energy Agency

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion